# DBV Technologies S.A.: filings

DBVT · Nasdaq · CIK 1613780 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dbvt.md) · [Financials](/companies/dbvt/financials.md) · [Filings](/companies/dbvt/filings.md) · [Insiders](/companies/dbvt/insiders.md)

## Reports and events: 335 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 197, 8-K 75, 4 39, SC 13G/A 30, 3 22, 10-Q 18, SCHEDULE 13G/A 15, SC 13G 13, CORRESP 12, SC 13D/A 12, UPLOAD 11, 424B5 10, EFFECT 10, SCHEDULE 13G 9, SCHEDULE 13D/A 7, 10-K 6, 20-F 6, DEF 14A 6, PRE 14A 6, S-8 6, S-3 5, 424B3 4, ARS 4, DEFA14A 4, F-1/A 4, 10-K/A 3, 8-K/A 3, 424B4 2, CT ORDER 2, F-1 2, F-3ASR 2, FWP 2, SC 13D 2, 20-F/A 1, 6-K/A 1, 8-A12B 1, CERTNAS 1, D 1, DRS 1, DRS/A 1, F-1MEF 1, F-3 1, F-3MEF 1, NT 10-K 1, POS AM 1, POSASR 1, PRER14A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:24 ET | [8-K](/filings/0001193125-26-436411.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436411 |
| 2026-10-28 | 16:54 ET | [10-Q](/filings/0001628280-26-067930.md) | Quarterly report, period 2026-09-30 | 0001628280-26-067930 |
| 2026-09-30 | 21:18 ET | [8-K](/filings/0001193125-26-408052.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-408052 |
| 2026-07-16 | 17:02 ET | [8-K](/filings/0001193125-26-306222.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-306222 |
| 2026-07-16 | 16:08 ET | [10-Q](/filings/0001628280-26-048453.md) | Quarterly report, period 2026-06-30 | 0001628280-26-048453 |
| 2026-06-29 | 16:28 ET | [8-K](/filings/0001193125-26-288533.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-288533 |
| 2026-06-05 | 16:01 ET | [8-K](/filings/0001193125-26-259488.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-259488 |
| 2026-06-03 | 16:05 ET | [8-K](/filings/0001193125-26-255414.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255414 |
| 2026-05-11 | 06:55 ET | [DEF 14A](/filings/0001193125-26-215657.md) | Proxy statement, period 2026-06-03 | 0001193125-26-215657 |
| 2026-05-05 | 16:01 ET | [8-K](/filings/0001193125-26-206315.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-206315 |
| 2026-04-30 | 17:30 ET | [8-K](/filings/0001193125-26-197921.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-197921 |
| 2026-04-30 | 16:24 ET | [10-Q](/filings/0001628280-26-028929.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028929 |
| 2026-04-30 | 16:03 ET | [10-K/A](/filings/0001193125-26-197148.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197148 |
| 2026-03-26 | 17:25 ET | [8-K](/filings/0001193125-26-126671.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-126671 |
| 2026-03-26 | 17:18 ET | [10-K](/filings/0001628280-26-021504.md) | Annual report, period 2025-12-31 | 0001628280-26-021504 |
| 2026-03-02 | 07:54 ET | [8-K](/filings/0001193125-26-084251.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084251 |
| 2026-01-20 | 20:29 ET | [8-K](/filings/0001193125-26-015592.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-015592 |
| 2026-01-14 | 17:36 ET | [SCHEDULE 13D/A](/filings/0001104659-26-003806.md) | Ownership report, active investor, amended | 0001104659-26-003806 |
| 2026-01-07 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001104659-26-001744.md) | Ownership report, active investor, amended | 0001104659-26-001744 |
| 2026-01-05 | 16:02 ET | [SCHEDULE 13D/A](/filings/0001104659-26-000611.md) | Ownership report, active investor, amended | 0001104659-26-000611 |
| 2025-12-19 | 18:32 ET | [SCHEDULE 13D/A](/filings/0001104659-25-123340.md) | Ownership report, active investor, amended | 0001104659-25-123340 |
| 2025-12-16 | 16:21 ET | [8-K](/filings/0001193125-25-320901.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-320901 |
| 2025-11-04 | 16:14 ET | [SCHEDULE 13D/A](/filings/0001104659-25-106287.md) | Ownership report, active investor, amended | 0001104659-25-106287 |
| 2025-10-30 | 16:49 ET | [8-K](/filings/0001193125-25-258780.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-258780 |
| 2025-10-29 | 17:40 ET | [8-K](/filings/0001193125-25-253968.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-253968 |
| 2025-10-28 | 16:44 ET | [10-Q](/filings/0001628280-25-046809.md) | Quarterly report, period 2025-09-30 | 0001628280-25-046809 |
| 2025-09-18 | 16:42 ET | [8-K](/filings/0001193125-25-207507.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-207507 |
| 2025-09-05 | 16:38 ET | [8-K](/filings/0001193125-25-197277.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-197277 |
| 2025-07-29 | 17:28 ET | [8-K](/filings/0001193125-25-168148.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-168148 |
| 2025-07-29 | 16:01 ET | [10-Q](/filings/0001613780-25-000016.md) | Quarterly report, period 2025-06-30 | 0001613780-25-000016 |
| 2025-06-25 | 16:32 ET | [8-K](/filings/0001193125-25-146994.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-146994 |
| 2025-06-11 | 16:05 ET | [8-K](/filings/0001193125-25-139137.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-139137 |
| 2025-05-15 | 16:06 ET | [DEF 14A](/filings/0001193125-25-120788.md) | Proxy statement, period 2025-06-11 | 0001193125-25-120788 |
| 2025-05-14 | 16:05 ET | [10-K/A](/filings/0001193125-25-119836.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-119836 |
| 2025-04-30 | 16:46 ET | [8-K](/filings/0001193125-25-107505.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-107505 |
| 2025-04-30 | 16:02 ET | [10-Q](/filings/0001613780-25-000011.md) | Quarterly report, period 2025-03-31 | 0001613780-25-000011 |
| 2025-04-28 | 17:09 ET | [10-K/A](/filings/0001193125-25-100826.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-100826 |
| 2025-04-11 | 16:05 ET | [10-K](/filings/0001613780-25-000006.md) | Annual report, period 2024-12-31 | 0001613780-25-000006 |
| 2025-04-07 | 16:50 ET | [SCHEDULE 13D/A](/filings/0001104659-25-032674.md) | Ownership report, active investor, amended | 0001104659-25-032674 |
| 2025-03-31 | 19:35 ET | [SCHEDULE 13D/A](/filings/0001104659-25-030053.md) | Ownership report, active investor, amended | 0001104659-25-030053 |
| 2025-03-31 | 16:02 ET | [8-K](/filings/0001193125-25-068727.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-068727 |
| 2025-03-24 | 07:01 ET | [8-K](/filings/0001193125-25-060850.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-060850 |
| 2025-01-08 | 17:30 ET | [8-K](/filings/0001193125-25-003574.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-003574 |
| 2024-12-18 | 16:06 ET | [8-K](/filings/0001193125-24-281283.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-281283 |
| 2024-12-16 | 16:06 ET | [8-K](/filings/0001193125-24-279571.md) | 3.01 Delisting notice | 0001193125-24-279571 |
| 2024-12-11 | 16:42 ET | [8-K](/filings/0001193125-24-275646.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-275646 |
| 2024-11-12 | 07:30 ET | [8-K](/filings/0001193125-24-255153.md) | 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255153 |
| 2024-11-06 | 17:19 ET | [8-K](/filings/0001193125-24-252203.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252203 |
| 2024-11-06 | 16:34 ET | [10-Q](/filings/0001613780-24-000007.md) | Quarterly report, period 2024-09-30 | 0001613780-24-000007 |
| 2024-10-22 | 16:53 ET | [8-K](/filings/0001193125-24-241114.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-241114 |

Page 1 of 7. [Older](/companies/dbvt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 05:16 ET. No prices; not investment advice.